Apellis Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of APLS for the last quarter is 172.32 M USD, and it's 17.73% higher compared to the previous quarter. The net income of Q1 24 is -66.42 M USD.